4.7 Article

Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response

Journal

EBIOMEDICINE
Volume 27, Issue -, Pages 156-166

Publisher

ELSEVIER
DOI: 10.1016/j.ebiom.2017.11.028

Keywords

Data fusion; Cancer driver gene discovery; Module network

Funding

  1. National Institute of Dental & Craniofacial Research (NIDCR) [U01 DE025188]
  2. National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R01 EB020527]
  3. National Cancer Institute (NCI) Informatics Technology for Cancer Research (ITCR) [R21 CA209940]

Ask authors/readers for more resources

The availability of increasing volumes of multi-omics profiles across many cancers promises to improve our understanding of the regulatory mechanisms underlying cancer. The main challenge is to integrate these multiple levels of omics profiles and especially to analyze them across many cancers. Here we present AMARETTO, an algorithm that addresses both challenges in three steps. First, AMARETTO identifies potential cancer driver genes through integration of copy number, DNA methylation and gene expression data. Then AMARETTO connects these driver genes with co-expressed target genes that they control, defined as regulatory modules. Thirdly, we connect AMARETTO modules identified from different cancer sites into a pancancer network to identify cancer driver genes. Here we applied AMARETTO in a pancancer study comprising eleven cancer sites and confirmed that AMARETTO captures hallmarks of cancer. We also demonstrated that AMARETTO enables the identification of novel pancancer driver genes. In particular, our analysis led to the identification of pancancer driver genes of smoking-induced cancers and 'antiviral' interferon-modulated innate immune response. Software availability: AMARETTO is available as an R package at https://bitbucket.org/gevaertlab/pancanceramaretto. (c) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available